Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Data from BARFOT, a multicentre study of rheumatoid arthritis
(2013) In Clinical and Experimental Rheumatology 31(1). p.122-124- Abstract
- Objective. We studied the prevalence and effect on disease activity of ever having had second-hand exposure to tobacco smoke in Swedish rheumatoid arthritis (RA) patients who had never smoked. Methods. Between 1992 and 2005, 2,800 patients were included in the BARFOT early-RA study in Sweden. Disease Activity Score 28 joints (DAS28), C-reactive protein (CRP), Health Assessment Questionnaire (HAQ), rheumatoid factor (RF), general health and pain visual analogue scales (VAS), and drug treatment were registered at inclusion and at follow-up at 3, 6, and 12 months and 2 and 5 years. EULAR response criteria were applied at the same follow-up points. In 2010, a self-completion postal questionnaire was sent to 2,102 patients in the BARFOT study... (More)
- Objective. We studied the prevalence and effect on disease activity of ever having had second-hand exposure to tobacco smoke in Swedish rheumatoid arthritis (RA) patients who had never smoked. Methods. Between 1992 and 2005, 2,800 patients were included in the BARFOT early-RA study in Sweden. Disease Activity Score 28 joints (DAS28), C-reactive protein (CRP), Health Assessment Questionnaire (HAQ), rheumatoid factor (RF), general health and pain visual analogue scales (VAS), and drug treatment were registered at inclusion and at follow-up at 3, 6, and 12 months and 2 and 5 years. EULAR response criteria were applied at the same follow-up points. In 2010, a self-completion postal questionnaire was sent to 2,102 patients in the BARFOT study enquiring about lifestyle habits such as whether they had ever been exposed to tobacco smoke as a result of someone else smoking. Results. A total of 96311,421 patients (68%) had had second-hand exposure to tobacco smoke. At 3, 6, and 12 months, at 2 years, and at 5 years of follow-up, there were no differences in EULAR response between patients who had never smoked and who had been exposed or had not been exposed second-hand to tobacco smoke (p=0.91, p=0.88, p=0.84, p=0.61 and p=0.85, respectively). Conclusions. We did not find any association between second-hand exposure to tobacco smoke and disease activity in RA. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3658120
- author
- Soderlin, M. K. ; Andersson, M. and Bergman, Stefan LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- rheumatoid arthritis, second-hand smoke, exposure, environmental tobacco, smoke, epidemiology
- in
- Clinical and Experimental Rheumatology
- volume
- 31
- issue
- 1
- pages
- 122 - 124
- publisher
- Pacini
- external identifiers
-
- wos:000315758500018
- scopus:84874891427
- ISSN
- 1593-098X
- language
- English
- LU publication?
- yes
- id
- b1b743ef-05b4-4769-8ef9-78fc599032b0 (old id 3658120)
- date added to LUP
- 2016-04-01 10:09:56
- date last changed
- 2022-01-25 20:25:33
@article{b1b743ef-05b4-4769-8ef9-78fc599032b0, abstract = {{Objective. We studied the prevalence and effect on disease activity of ever having had second-hand exposure to tobacco smoke in Swedish rheumatoid arthritis (RA) patients who had never smoked. Methods. Between 1992 and 2005, 2,800 patients were included in the BARFOT early-RA study in Sweden. Disease Activity Score 28 joints (DAS28), C-reactive protein (CRP), Health Assessment Questionnaire (HAQ), rheumatoid factor (RF), general health and pain visual analogue scales (VAS), and drug treatment were registered at inclusion and at follow-up at 3, 6, and 12 months and 2 and 5 years. EULAR response criteria were applied at the same follow-up points. In 2010, a self-completion postal questionnaire was sent to 2,102 patients in the BARFOT study enquiring about lifestyle habits such as whether they had ever been exposed to tobacco smoke as a result of someone else smoking. Results. A total of 96311,421 patients (68%) had had second-hand exposure to tobacco smoke. At 3, 6, and 12 months, at 2 years, and at 5 years of follow-up, there were no differences in EULAR response between patients who had never smoked and who had been exposed or had not been exposed second-hand to tobacco smoke (p=0.91, p=0.88, p=0.84, p=0.61 and p=0.85, respectively). Conclusions. We did not find any association between second-hand exposure to tobacco smoke and disease activity in RA.}}, author = {{Soderlin, M. K. and Andersson, M. and Bergman, Stefan}}, issn = {{1593-098X}}, keywords = {{rheumatoid arthritis; second-hand smoke; exposure; environmental tobacco; smoke; epidemiology}}, language = {{eng}}, number = {{1}}, pages = {{122--124}}, publisher = {{Pacini}}, series = {{Clinical and Experimental Rheumatology}}, title = {{Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Data from BARFOT, a multicentre study of rheumatoid arthritis}}, volume = {{31}}, year = {{2013}}, }